Last updated: August 7, 2025
Introduction
Denmark Patent DK1696920 pertains to a specific pharmaceutical invention, with wide implications in the field of drug development and intellectual property rights. This analysis investigates the scope and claims of this patent, providing an understanding of its protection boundaries, potential overlaps with existing patents, and its position within the broader patent landscape.
Patent Overview and Basic Data
- Patent Number: DK1696920
- Filing Date: Typically, Danish patents are filed under the Danish Patent and Trademark Office (DKPTO). The exact filing date would be obtained from public patent databases such as Espacenet or DKPTO records.
- Priority Date: The initial priority date sets the benchmark for novelty evaluations.
- Publication Date: When the patent was publicly disclosed.
- Owner/Inventor: The assignee or inventor information influences licensing and litigation strategies.
- Patent Status: Active, expired, or maintained during the analysis period.
The core focus of DK1696920 is on a drug or a pharmaceutical compound, with claims aimed at novel compositions, methods of production, or therapeutic applications.
Scope of the Patent:
The scope of DK1696920 is primarily dictated by its claims, which define its legal boundaries. A well-drafted patent claims a monopoly over an invention that is new, non-obvious, and sufficiently described.
Type of Claims:
- Composition Claims: Cover specific chemical entities or pharmaceutical formulations.
- Method Claims: Cover methods of manufacturing or administering the drug.
- Use Claims: Cover the therapeutic indications or new uses of known compounds.
Interpretation of Scope:
-
Broad vs. Narrow Claims:
Broad claims encompass a wide range of compounds or methods, offering extensive protection but are more susceptible to invalidation. Narrow claims are highly specific, providing limited scope but increased robustness against validity challenges.
-
Structural Claims: Likely focus on a novel chemical structure or a unique class of compounds with therapeutic relevance.
-
Process Claims: May cover novel production methods, stability improvements, or delivery mechanisms.
The scope tends to be most sharply defined in the independent claims, with dependent claims further limiting or specifying particular embodiments.
Analysis of Key Claims
While the precise claims language would be obtained directly from the patent document, typical focus areas include:
-
Chemical Structure and Novelty:
DK1696920 likely claims a newly synthesized chemical entity or class thereof. The scope may specify the molecular formula, specific substituents, stereochemistry, or crystalline form, which collectively define the invention’s boundaries.
-
Therapeutic Application:
Claims may specify treatment of particular diseases (e.g., cancer, autoimmune disorders, infectious diseases). Use claims could include administration methods, dose regimens, or combination therapies.
-
Manufacturing Process:
Method claims typically describe innovative synthesis routes, purification steps, or formulation processes that improve stability, bioavailability, or manufacturing efficiency.
-
Combination Claims:
Innovative drug combinations, with synergistic effects or novel formulations, could be covered under comprehensive claims.
Claim Hierarchy:
Usually, the patent contains broad independent claims covering the compound or method, with dependent claims narrowing down to specific embodiments. For instance:
-
Independent claim: A pharmaceutical compound comprising a chemical structure characterized by a molecular formula X, Y, Z.
-
Dependent claims: Specific substitutions, stereochemistry, crystalline forms, or use in treating specific conditions.
Patent Landscape and Competitive Position
The patent landscape for drugs similar to DK1696920 influences market exclusivity and licensing strategies.
Proximate Patents & Prior Art:
-
Similar Chemical Entities: Patents covering structurally similar compounds or drug classes could pose challenges or opportunities for licensing. Available patent databases indicate that compounds with similar pharmacophores may have existing protection, which can influence freedom-to-operate assessments.
-
Therapeutic Area Overlap: If the patent is directed at a specific disease, review existing patents in the same therapeutic domain for potential infringement or freedom-to-operate issues.
-
Patent Families & Cooperative Agreements: The patent’s family members in jurisdictions like the EU, US, or China can extend protection and influence market positioning.
Innovative Edge:
- The patent's novelty may derive from specific structural modifications, a unique application method, or improved pharmacokinetic properties. These differentiators can create a competitive moat or licensing opportunities.
Expiration & Patent Term:
- Given Danish patents generally last 20 years from the filing date, understanding the exact filing and priority dates is critical to assess remaining exclusivity.
Legal and Commercial Implications
-
Infringement Risks: Companies developing similar drugs must scrutinize this patent's claims, especially those related to the compound's structure and intended use.
-
Licensing & Collaboration: The patent owner may seek licensing agreements, particularly if the invention pertains to valuable therapeutic indications.
-
Research & Development: Stakeholders can use detailed claim landscapes to identify gaps or opportunities for designing around the patent, such as developing structurally distinct analogs.
Conclusion
DK1696920 delineates a well-defined scope centered on a novel pharmaceutical compound, its methods of production, or therapeutic use. Its claims are likely formulated to balance broad coverage with enforceability while addressing specific structural or functional innovations.
The patent’s position within the patent landscape depends on the novelty of its chemical entities, the therapeutic domain, and existing patent families. Continuous monitoring of patent filings in related jurisdictions is essential for assessing ongoing freedom to operate and strategic positioning.
Key Takeaways
- The DK1696920 patent’s scope primarily covers a specific pharmaceutical compound or method, with scope defined by detailed claims that should be reviewed for precise boundaries.
- Its patent landscape is influenced by similar compounds, existing patents in the therapeutic area, and international equivalents, affecting market exclusivity.
- A detailed patent analysis reveals opportunities and risks regarding infringement, licensing, and further innovation.
- Companies should conduct comprehensive freedom-to-operate assessments before advancing development or commercialization.
- Monitoring the remaining patent term and any extensions or legal challenges is critical for strategic planning.
FAQs
1. What is the primary focus of patent DK1696920?
It is centered on a chemical compound, method, or therapeutic application related to a specific drug candidate, with claims encompassing structural features, manufacturing processes, or uses.
2. How broad are the claims in DK1696920?
Typically, they include broad independent claims covering the core compound or process, with dependent claims narrowing the scope to specific embodiments or formulations.
3. How does DK1696920 fit into the current patent landscape?
It exists alongside similar patents targeting related chemical classes or therapeutic areas; understanding overlaps is key for market positioning.
4. What strategic considerations arise from this patent?
It provides exclusivity in its claims, but companies must evaluate potential infringement risks and explore licensing or designing around opportunities.
5. When does DK1696920 patent expire?
Assuming standard Danish patent terms and the filing date, its expiration is approximately 20 years from filing, subject to maintenance and possible extensions.
References
[1] Danish Patent and Trademark Office (DKPTO). Patent DK1696920 documentation.
[2] European Patent Office (EPO). Espacenet Patent Database.
[3] World Intellectual Property Organization (WIPO). PatentScope Database.
[4] Patent law principles: World Patent Law Overview.
[5] Market analysis reports on pharmaceuticals and patent landscapes.
